Related Experiment Video
Updated: Jul 6, 2026

Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion
Published on: March 18, 2014
Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung
T Sethi1, R C Rintoul, S M Moore
1Respiratory Medicine Unit, Rayne Laboratory, University of Edinburgh Medical School, Scotland, UK. t.sethi@ed.ac.uk
Small cell lung cancer (SCLC) cells adhere to extracellular matrix (ECM), which promotes tumor growth and chemotherapy resistance by blocking apoptosis. Targeting beta1 integrin may improve SCLC treatment response.
Area of Science:
- Oncology
- Cancer Biology
- Cellular Microenvironment
Background:
- Chemotherapy resistance is a major challenge in treating small cell lung cancer (SCLC).
- SCLC tumors are characterized by an extensive extracellular matrix (ECM) stroma.
- The interaction between cancer cells and their microenvironment significantly influences tumor progression and treatment outcomes.
Purpose of the Study:
- To investigate the role of extracellular matrix (ECM) and beta1 integrin signaling in SCLC chemotherapy resistance.
- To explore the potential of targeting beta1 integrin as a therapeutic strategy for SCLC.
Main Methods:
- Analysis of SCLC primary and metastatic sites to characterize the tumor microenvironment.
- Investigating the effects of SCLC cell adhesion to ECM on tumorigenicity and chemoresistance.
- Examining the role of beta1 integrin-mediated tyrosine kinase activation in suppressing chemotherapy-induced apoptosis.
Main Results:
- SCLC cells are embedded within an extensive ECM stroma.
- Adhesion of SCLC cells to ECM enhances tumorigenicity and confers resistance to chemotherapy.
- Beta1 integrin activation suppresses chemotherapy-induced apoptosis, contributing to treatment resistance.
- This ECM-mediated survival mechanism may explain clinical observations of partial responses and recurrence in SCLC.
Conclusions:
- The tumor microenvironment, specifically ECM-SCLC cell adhesion via beta1 integrin, plays a critical role in chemotherapy resistance.
- Blocking beta1 integrin-mediated survival signals presents a potential novel therapeutic strategy to enhance chemotherapy efficacy in SCLC.
Related Concept Videos
The Extracellular Matrix
Mitogens and the Cell Cycle
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
Cell-matrix's Response to Mechanical Forces
Anchoring junctions mechanically attach a cell to the...

